Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia

doi:10.5498/wjp.v10.i4.29

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5497)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

379

WORD

284

HTML

3213

Tables (1-3)

263

Sum=4139

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

719

Download

639

Sum=1358

Apr 19, 2020 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Psychiatr. Apr 19, 2020; 10(4): 29-33
Published online Apr 19, 2020. doi: 10.5498/wjp.v10.i4.29

Table 1 Summary of included studies

Ref.	Country of origin	Number of participants	Age (yr)	Setting	Comparators	Duration
Cummings et al[8], 2015	United States	220	50-90	Outpatient clinics, assisted living and nursing facilities	Dextromethorphan-quinidine vs placebo	10 wk

Citation: Tampi RR, Joshi P, Marpuri P, Tampi DJ. Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia. World J Psychiatr 2020; 10(4): 29-33
URL: https://www.wjgnet.com/2220-3206/full/v10/i4/29.htm
DOI: https://dx.doi.org/10.5498/wjp.v10.i4.29